FIS1 and amyotrophic lateral sclerosis: However, other recent papers have shown the efficacy of a molecule able to inhibit the interaction DRP1/FIS1, which blocks pathological or excessive mitochondrial fragmentation seen in ALS and cardiac diseases without affecting basal mitochondrial fission (Haileselassie et al., 2019).